# Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury

> **NCT06847555** · PHASE1,PHASE2 · RECRUITING · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 24 (estimated)

## Conditions studied

- To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients

## Interventions

- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT06847555
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-25
- **Primary completion:** 2027-09-25
- **Final completion:** 2027-09-25
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06847555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06847555, "Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06847555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*